22438257 |
Cell transformation by FLT3 ITD in acute myeloid leukemia involves oxidative inactivation of the tumor suppressor protein-tyrosine phosphatase DEP-1/ PTPRJ
Bauer, R,
Godfrey, R,
Müller, JP,
Schnetzke, U,
Dagnell, M,
Böhmer, SA,
Heinrich, T,
Böhmer, FD,
Arora, D,
Stopp, S,
Östman, A,
Scholl, S
|
Blood |
2012 |
29372308 |
Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 display a higher oncogenic potential than the activation loop D835Y mutation
Heidel, F,
Rönnstrand, L,
Fischer, T,
Marhäll, A
|
|
2018 |
15498859 |
Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival
Levis, M,
Ahn, JY,
Small, D,
Lilly, M,
Kim, KT,
Meltzer, P,
Baird, K
|
Blood |
2005 |
15718420 |
FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model
Grundler, R,
Duyster, J,
Peschel, C,
Thiede, C,
Miething, C
|
|
2005 |
10698507 |
Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines
Hayakawa, F,
Saito, H,
Towatari, M,
Tanimoto, M,
Naoe, T,
Kitamura, T,
Kiyoi, H
|
Oncogene |
2000 |
17356133 |
Activation mechanisms of STAT5 by oncogenic Flt3-ITD
Berdel, WE,
Serve, H,
Sargin, B,
Ueker, A,
Böhmer, FD,
Brandts, C,
Tickenbrock, L,
Choudhary, C,
Müller-Tidow, C,
Schwäble, J
|
Blood |
2007 |
23103841 |
The protein tyrosine phosphatase, Shp2, positively contributes to FLT3-ITD-induced hematopoietic progenitor hyperproliferation and malignant disease in vivo
Boswell, HS,
Ramdas, B,
Feng, GS,
Zeng, L,
Kapur, R,
He, Y,
Liu, Z,
Zhang, X,
Sandusky, GE,
Zhang, ZY,
Fukuda, S,
Li, XJ,
Nabinger, SC,
Yu, M,
Richine, B,
Chan, RJ,
Goenka, S,
Bowling, JD
|
Leukemia |
2013 |
15769897 |
AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations
Berdel, WE,
Serve, H,
Sargin, B,
Kindler, T,
Brandts, C,
Tickenbrock, L,
Choudhary, C,
Müller-Tidow, C,
Fischer, T,
Schwäble, J
|
|
2005 |
15003515 |
Flt3 mutation activates p21WAF1/CIP1 gene expression through the action of STAT5
Licht, JD,
Harigae, H,
Takahashi, S,
Kaku, M,
Sasaki, T
|
Biochem. Biophys. Res. Commun. |
2004 |
15626738 |
FLT3-ITD-TKD dual mutants associated with AML confer resistance to FLT3 PTK inhibitors and cytotoxic agents by overexpression of Bcl-x(L)
Ellwart, JW,
Reindl, C,
Spiekermann, K,
Geisenhof, S,
Kern, R,
Bagrintseva, K,
Hiddemann, W,
Eichenlaub, S
|
Blood |
2005 |
26716518 |
STAT5 in Cancer and Immunity
Murphy, JJ,
Rani, A
|
J. Interferon Cytokine Res. |
2016 |
16410449 |
Point mutations in the juxtamembrane domain of FLT3 define a new class of activating mutations in AML
Schnittger, S,
Ellwart, JW,
Hopfner, KP,
Reindl, C,
Spiekermann, K,
Wenig, K,
Vempati, S,
Bagrintseva, K,
Hiddemann, W
|
Blood |
2006 |